BAY3427080

DRUG2 trials

Sponsors

Bayer

Conditions

Post-menopausal Vasomotor SymptomsVasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Phase 1

Evaluation of the Pharmacokinetics and Safety of BAY3427080 (NT-814) in Post-Menopausal Women With Vasomotor Symptoms

CompletedNCT02865538

BayerPost-menopausal Vasomotor Symptoms

Start: 2016-08-01End: 2017-03-28Updated: 2025-02-07

A Study to Learn How Different Levels of Decreased Liver Function Influence Blood Levels of Elinzanetant Compared to Normal Liver Function in Male and Female Participants

CompletedNCT04903821

BayerVasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Start: 2021-06-01End: 2022-03-15Updated: 2022-03-24